RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260703

FDA DEVICE FACTS

Powder Free Blue Nitrile Examination Glove - Tested for Use with Chemotherapy Drugs and Fentanyl;Powder Free Black Nitrile Examination Glove - Tested for Use with Chemotherapy Drugs and Fentanyl

S&S Glove Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 3, 2026PRODUCT CODELZACLINICAL AREAPatient Monitoring

Indications for use

Powder Free Blue Nitrile Examination Glove- Tested for Use with Chemotherapy Drugs and Fentanyl: The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs and Fentanyl Citrate using ASTM D6978-05. The following chemicals have been tested with these gloves: Chemotherapy Drugs | Concentration mg/ml | Breakthrough Detection Time in Minutes 1 Carmustine | 3.3mg/ml (3,300 ppm) | 22.7 min 2 Cisplatin | 1mg/ml (1,000 ppm) | >240min 3 Cyclophosphamide | 20mg/ml (20,000 ppm) | >240min 4 Dacarbazine (DTIC) | 10mg/ml (10,000 ppm) | >240min 5 Doxorubicin HCI (Adriamycin) | 2mg/ml (2,000 ppm) | >240min 6 Etoposide (Toposar) | 20mg/ml (20,000 ppm) | >240min 7 Fluorouracil (5 Flu) | 50mg/ml (50,000 ppm) | >240min 8 Methotrexate | 25mg/ml (25,000 ppm) | >240min 9 Mitomycin C | 0.5 mg/ml (500 ppm) | >240min 10 Mitoxantrone HCI | 2mg/ml (2,000 ppm) | >240min 11 Paclitaxel (Taxol) | 6mg/ml (6,000 ppm) | >240min 12 Thio-Tepa | 10mg/ml (10,000 ppm) | 11.1 min 13 Vincristine Sulphate | 1mg/ml (1,000 ppm) | >240 min Non-chemotherapy Drugs | Concentration mg/ml | Breakthrough Detection Time in Minutes 1 Fentanyl Citrate | 100mcg/2ml | >240min Testing showed an average breakthrough time of 11.1 minutes with Thio-Tepa, 10mg/ml (10,000 ppm) and 22.7 minutes with Carmustine, 3.3mg/ml (3,300 ppm) Warning: Do not use with Carmustine and Thiotepa Powder Free Black Nitrile Examination Glove - Tested for Use with Chemotherapy Drugs and Fentanyl: The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs and Fentanyl Citrate using ASTM D6978-05. The following chemicals have been tested with these gloves: Chemotherapy Drugs | Concentration mg/ml | Breakthrough Detection Time in Minutes 1 Carmustine | 3.3mg/ml (3,300 ppm) | 21.4 min 2 Cisplatin | 1mg/ml (1,000 ppm) | >240min 3 Cyclophosphamide | 20mg/ml (20,000 ppm) | >240min 4 Dacarbazine (DTIC) | 10mg/ml (10,000 ppm) | >240min 5 Doxorubicin HCI (Adriamycin) | 2mg/ml (2,000 ppm) | >240min 6 Etoposide (Toposar) | 20mg/ml (20,000 ppm) | >240min 7 Fluorouracil (5 Flu) | 50mg/ml (50,000 ppm) | >240min 8 Methotrexate | 25mg/ml (25,000 ppm) | >240min 9 Mitomycin C | 0.5 mg/ml (500 ppm) | >240min 10 Mitoxantrone HCI | 2mg/ml (2,000 ppm) | >240min 11 Paclitaxel (Taxol) | 6mg/ml (6,000 ppm) | >240min 12 Thio-Tepa | 10mg/ml (10,000 ppm) | 15.5 min 13 Vincristine Sulphate | 1mg/ml (1,000 ppm) | >240 min Non-chemotherapy Drugs | Concentration mg/ml | Breakthrough Detection Time in Minutes 1 Fentanyl Citrate | 100mcg/2ml | >240min Testing showed an average breakthrough time of 15.5 minutes with Thio-Tepa, 10mg/ml (10,000 ppm) and 21.4 minutes with Carmustine, 3.3mg/ml (3,300 ppm). Warning: Do not use with Carmustine and Thiotepa

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026